La Jolla, CA, United States of America

Jochen Stritzker

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jochen Stritzker

Introduction

Jochen Stritzker is a notable inventor based in La Jolla, California. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of three patents to his name, Stritzker's work focuses on enhancing the efficacy of adoptive T cell therapy.

Latest Patents

Stritzker's latest patents include methods for combining adoptive T cell therapy with oncolytic virus adjunct therapy. This invention aims to augment the effects of adoptive T cell therapy, such as TVAX Immunotherapy, by using adjunct treatment with an oncolytic virus, like a vaccinia virus. The goal is to treat various types of cancer or other proliferative disorders. Additionally, immunomodulatory compounds can be utilized to further enhance the effects of the therapy.

Career Highlights

Throughout his career, Jochen Stritzker has worked with several companies, including Tvax Biomedical I, LLC and Genelux Corporation. His experience in these organizations has contributed to his expertise in the field of immunotherapy and cancer treatment.

Collaborations

Stritzker has collaborated with notable individuals in his field, including Gary Wood and Aladar A Szalay. These partnerships have likely enriched his research and development efforts.

Conclusion

Jochen Stritzker's innovative work in cancer treatment through his patents demonstrates his commitment to advancing medical science. His contributions are paving the way for more effective therapies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…